These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21874572)

  • 1. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects.
    Al-Wahsh I; Wu Y; Liebman M
    Urol Res; 2012 Jun; 40(3):191-6. PubMed ID: 21874572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.
    Okombo J; Liebman M
    Urol Res; 2010 Jun; 38(3):169-78. PubMed ID: 20224931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K; Akakura K; Takei K; Ueda T; Mizoguchi K; Noda M; Miyake M; Ito H
    Int J Urol; 2003 Jun; 10(6):293-6. PubMed ID: 12757596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of increased oxalate absorption in patients with calcium-containing renal stones.
    Hodgkinson A
    Clin Sci Mol Med; 1978 Mar; 54(3):291-4. PubMed ID: 630804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
    Knight J; Holmes RP; Assimos DG
    Urol Res; 2007 Jun; 35(3):111-7. PubMed ID: 17431604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial roles of gastrointestinal and urinary microbiomes in kidney stone prevention via their oxalate-degrading ability and beyond.
    Noonin C; Thongboonkerd V
    Microbiol Res; 2024 May; 282():127663. PubMed ID: 38422861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy.
    Afkari R; Feizabadi MM; Ansari-Moghadam A; Safari T; Bokaeian M
    Int Braz J Urol; 2019; 45(6):1249-1259. PubMed ID: 31808414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.
    Marangella M; Fruttero B; Bruno M; Linari F
    Clin Sci (Lond); 1982 Oct; 63(4):381-5. PubMed ID: 7105633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR; Reid SJ
    Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and other key determinants of dietary oxalate absorption.
    Liebman M; Al-Wahsh IA
    Adv Nutr; 2011 May; 2(3):254-60. PubMed ID: 22332057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion.
    Thomas E; von Unruh GE; Hesse A
    Eur J Clin Nutr; 2008 Sep; 62(9):1090-7. PubMed ID: 17609696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.
    Chai W; Liebman M; Kynast-Gales S; Massey L
    Am J Kidney Dis; 2004 Dec; 44(6):1060-9. PubMed ID: 15558527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.